White Paper
Those that work in the biopharmaceutical or device industry are likely familiar with the term synthetic controls. But what exactly are synthetic…
Page
The expertise of a global CRO + local know-how to deliver the highest caliber of clinical development services around the world.
Webcast
The growing focus on post-marketing and observational research has brought a heightened awareness, and scrutiny, on the design and execution of these…
Webcast
Late phase research has changed substantially over the past decade. During this period of innovation and development, many myths and misconceptions…
Webcast
As the number of preferred provider relationships grow and become more sophisticated, budget grids and assumptions must align with the needs of…
Webcast
While Phase II-III studies include small datasets, comprising several hundred to several thousand patients, they provide the data necessary for drug…
Case Study
PRA Health Sciences Late Phase Services is participating in a global real world safety study program, mandated by various regulatory bodies, to…
Webcast
When new drugs are approved, the marketing authorization holders often have to commit themselves to perform additional post-authorization studies.…
White Paper
A summary of survey results from ISPOR’s Annual North America meeting, where we gathered insights on important developments in the real world…
White Paper
As our industry landscape for Real World Research has changed exponentially, our Real World Solutions team performed a short questionnaire at ISPOR…